Chemical process evolution of efavirenz, a potent non-nucleosidal HIV reverse transcriptase inhibitor. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Chemical process evolution of efavirenz, a potent non-nucleosidal HIV reverse transcriptase inhibitor.

Enantiomer. 1999;4(6):599-608. Unique Identifier : AIDSLINE MED/20136402
Chen CY; Tan L; Department of Process Research, Merck Research Laboratories,; Rahway, NJ 07065, USA. cheng_chen@merck.com


Keywords: JOURNAL ARTICLE HIV/ENZYMOLOGY Models, Molecular Molecular Structure Oxazines/*CHEMISTRY/*CHEMICAL SYNTHESIS Reverse Transcriptase Inhibitors/*CHEMISTRY/CHEMICAL SYNTHESIS StereoisomerismKWDjournalarticlehiv/enzymologymodels,molecularmolecularstructureoxazines/KWDchemistry/KWDchemicalsynthesisreversetranscriptaseinhibitors/KWDchemistry/chemicalsynthesisstereoisomerism
000530
A0052169

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .